FDA Import Refusal SCS-0973938-6/11/1 — BOEHRINGER INGELHEIM SA
The FDA refused shipment SCS-0973938-6/11/1 from BOEHRINGER INGELHEIM SA (Colombia) on Jul 17, 2020. The refused product falls under Drugs and Biologics — LINAGLIPTIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 17, 2020
- Country
- Colombia
- Product Category
- Drugs and Biologics
- Product Code
- 61PCB66 LINAGLIPTIN (ANTI-DIABETIC)
- Charges
- 75